Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH was delisted on the 10th of June, 2024.
140 hedge funds and large institutions have $450M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 49 closing their positions.
434% more call options, than puts
Call options by funds: $19.1M | Put options by funds: $3.57M
81% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 32
13% less funds holding
Funds holding: 161 → 140 (-21)
41% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 49
69% less capital invested
Capital invested by funds: $1.43B → $450M (-$982M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$89.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$85.7M |
| 3 |
Goldman Sachs
New York
|
+$60.2M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$56.5M |
| 5 |
AC
Armistice Capital
New York
|
+$51.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$109M |
| 2 |
O
OrbiMed
New York
|
-$74.2M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$63.3M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$62.9M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$61.6M |
DCPH Hedge Fund Activity: Q4 2021 in Review
140 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q4 2021, worth a combined $450M — down 69% from $1.43B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of DCPH and 29 opened new positions — a net loss of 20 holders — while 32 trimmed existing stakes and 58 added.
The largest buyer was Deerfield Management, adding an estimated $89.6M. The largest seller was Franklin Resources, exiting entirely with an estimated $109M sold.
- 140 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q4 2021, down from 161 in Q3 2021.
- Funds reported $450M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q4 2021, down 69% quarter-over-quarter.
- 29 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q4 2021 and 49 closed out, a net change of -20 holders.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q4 2021 was Deerfield Management, an estimated $89.6M added.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q4 2021 was Franklin Resources, an estimated $109M sold.
Based on aggregated 13F filings for Q4 2021.